Literature DB >> 15659507

Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation.

Michael A Andrykowski1, Michelle M Bishop, Elizabeth A Hahn, David F Cella, Jennifer L Beaumont, Marianne J Brady, Mary M Horowitz, Kathleen A Sobocinski, J Douglas Rizzo, John R Wingard.   

Abstract

PURPOSE: To examine health-related quality of life (HRQOL) and growth, and spiritual well-being in adult survivors of hematopoietic stem-cell transplantation (HSCT) for a malignant disease.
METHODS: HSCT survivors (n = 662) were recruited through the International Bone Marrow Transplant Registry/Autologous Blood and Marrow Transplant Registry and were drawn from 40 transplantation centers. HSCT survivors completed a telephone interview and a set of questionnaires a mean of 7.0 years post-HSCT (range, 1.8 to 22.6 years). Study measures included a variety of standardized measures of HRQOL and growth and spiritual well-being. An age- and sex-matched healthy comparison (HC) group (n = 158) was recruited using a peer nomination method. The HC group completed a parallel telephone interview and set of questionnaires.
RESULTS: Multivariate analysis of variance analyses found the HSCT survivor group reported poorer status relative to the HC group for all HRQOL outcome clusters including physical health, physical functioning, social functioning, psychological adjustment, and dyadic adjustment. In contrast, the HSCT survivor group reported more psychological and interpersonal growth. Mean effect size for the 24 outcome indices examined was 0.36 standard deviations, an effect size often considered clinically meaningful or important. The largest group differences were found for measures of general health, physical function and well-being, depression, cognitive function, and fatigue.
CONCLUSION: The experience of HSCT for a malignant disease has a wide-ranging, longstanding, and profound impact on adult recipients. Relative to healthy controls, HSCT survivors reported poorer physical, psychological, and social functioning but, conversely, more psychological and interpersonal growth, differences that appeared to persist many years after HSCT.

Entities:  

Mesh:

Year:  2005        PMID: 15659507     DOI: 10.1200/JCO.2005.03.189

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  102 in total

1.  Measuring musculoskeletal symptoms in cancer survivors who receive hematopoietic cell transplantation.

Authors:  Karen L Syrjala; Jean C Yi; Samantha B Artherholt; Allison C Stover; Janet R Abrams
Journal:  J Cancer Surviv       Date:  2010-05-08       Impact factor: 4.442

2.  Clinical predictors of cognitive function in adults treated with hematopoietic cell transplantation.

Authors:  Heather S L Jim; Brent Small; Sheri Hartman; Jamie Franzen; Shannon Millay; Kristin Phillips; Paul B Jacobsen; Margaret Booth-Jones; Joseph Pidala
Journal:  Cancer       Date:  2011-12-02       Impact factor: 6.860

3.  Spiritual Well-Being in Hispanic and Non-Hispanic Survivors of Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Patricia Prince; Sandra A Mitchell; Leslie Wehrlen; Richard Childs; Bipin Savani; Li Yang; Margaret Bevans
Journal:  J Psychosoc Oncol       Date:  2015

Review 4.  Patient-Reported Outcomes with Chimeric Antigen Receptor T Cell Therapy: Challenges and Opportunities.

Authors:  Rajshekhar Chakraborty; Surbhi Sidana; Gunjan L Shah; Michael Scordo; Betty K Hamilton; Navneet S Majhail
Journal:  Biol Blood Marrow Transplant       Date:  2018-11-28       Impact factor: 5.742

5.  An online randomized controlled trial, with or without problem-solving treatment, for long-term cancer survivors after hematopoietic cell transplantation.

Authors:  Karen L Syrjala; Jean C Yi; Samantha B Artherholt; Joan M Romano; Marie-Laure Crouch; Allison S Fiscalini; Mark T Hegel; Mary E D Flowers; Paul J Martin; Wendy M Leisenring
Journal:  J Cancer Surviv       Date:  2018-05-05       Impact factor: 4.442

6.  Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study.

Authors:  Christopher J Fraser; Smita Bhatia; Kirsten Ness; Andrea Carter; Liton Francisco; Mukta Arora; Pablo Parker; Stephen Forman; Daniel Weisdorf; James G Gurney; K Scott Baker
Journal:  Blood       Date:  2006-06-20       Impact factor: 22.113

Review 7.  National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Patient-Centered Outcomes Working Group Report.

Authors:  Margaret Bevans; Areej El-Jawahri; D Kathryn Tierney; Lori Wiener; William A Wood; Flora Hoodin; Erin E Kent; Paul B Jacobsen; Stephanie J Lee; Matthew M Hsieh; Ellen M Denzen; Karen L Syrjala
Journal:  Biol Blood Marrow Transplant       Date:  2016-09-19       Impact factor: 5.742

8.  Sexual function changes during the 5 years after high-dose treatment and hematopoietic cell transplantation for malignancy, with case-matched controls at 5 years.

Authors:  Karen L Syrjala; Brenda F Kurland; Janet R Abrams; Jean E Sanders; Julia R Heiman
Journal:  Blood       Date:  2007-09-18       Impact factor: 22.113

9.  Feasibility of frequent patient-reported outcome surveillance in patients undergoing hematopoietic cell transplantation.

Authors:  William A Wood; Allison M Deal; Amy Abernethy; Ethan Basch; Claudio Battaglini; Yoon Hie Kim; Julia Whitley; Charlotte Shatten; Jon Serody; Thomas Shea; Bryce B Reeve
Journal:  Biol Blood Marrow Transplant       Date:  2012-12-16       Impact factor: 5.742

10.  Long-term recovery after hematopoietic cell transplantation: predictors of quality-of-life concerns.

Authors:  F Lennie Wong; Liton Francisco; Kayo Togawa; Alysia Bosworth; Mitzi Gonzales; Cara Hanby; Melanie Sabado; Marcia Grant; Stephen J Forman; Smita Bhatia
Journal:  Blood       Date:  2010-01-20       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.